BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15796914)

  • 1. Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer.
    Xia Q; Kong XT; Zhang GA; Hou XJ; Qiang H; Zhong RQ
    Biochem Biophys Res Commun; 2005 May; 330(2):526-32. PubMed ID: 15796914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
    Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker identification in human pancreatic cancer sera.
    Hanas JS; Hocker JR; Cheung JY; Larabee JL; Lerner MR; Lightfoot SA; Morgan DL; Denson KD; Prejeant KC; Gusev Y; Smith BJ; Hanas RJ; Postier RG; Brackett DJ
    Pancreas; 2008 Jan; 36(1):61-9. PubMed ID: 18192883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
    He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
    Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing.
    Li WH; Zhao J; Li HY; Liu H; Li AL; Wang HX; Wang J; He K; Liang B; Yu M; Shen BF; Zhang XM
    Proteomics; 2006 Sep; 6(17):4781-9. PubMed ID: 16878294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
    Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
    Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
    Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum autoantibody against glutathione S-transferase in patients with glaucoma.
    Yang J; Tezel G; Patil RV; Romano C; Wax MB
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1273-6. PubMed ID: 11328739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immuno-proteomic screening of human pancreatic cancer associated membrane antigens for early diagnosis].
    Ning L; Pan B; Zhao YP; Liao Q; Zhang TP; Chen G; Wang WB; Yang YC
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):34-8. PubMed ID: 17403287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
    Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
    Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis.
    Yang F; Xiao ZQ; Zhang XZ; Li C; Zhang PF; Li MY; Chen Y; Zhu GQ; Sun Y; Liu YF; Chen ZC
    J Proteome Res; 2007 Feb; 6(2):751-8. PubMed ID: 17269731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
    Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
    J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
    Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
    Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
    Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
    Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.